Latest news with #CI&T
Business Wire
28-05-2025
- Business
- Business Wire
CI&T Is Recognised by Amazon Web Services for Excellence in Generative AI Solutions
LONDON--(BUSINESS WIRE)--CI&T (NYSE: CINT), a global digital transformation partner, has been awarded the Amazon Web Services (AWS) Generative AI Services Competency badge. The AWS Competency Program recognises partners with deep technical expertise and a proven track record of delivering innovative, cloud-based solutions. This achievement validates CI&T's capability to help organisations adopt and scale generative AI (GenAI) technologies to drive personalised experiences, process automation, and strategic value creation. 'This recognition reinforces our commitment to responsible innovation and meaningful impact,' said Felipe Demétrio de Souza, VP of Alliance at CI&T. 'We've already seen strong results from clients leveraging CI&T solutions to transform their operations with AI—always with a focus on security, scalability, and long-term vision. This badge is a testament to that work.' 'As we continue to expand in the UK and globally, our unique partnership with AWS plays a pivotal role in strengthening CI&T's position as a leader in tech acceleration. This recognition not only highlights our ingenuity in generative AI, but also reinforces our commitment to delivering pioneering, scalable solutions that turn insight into action for our clients across key industries in the region.' — Nick Curran, Chief Growth Officer at CI&T UK Generative AI in Action Several successful projects contributed to this recognition, including standout implementations with nima Educação and BASF, along with two additional well-rated use cases. nima Educação, one of Brazil's largest private higher education groups, partnered with CI&T to deploy an AI-powered system for automatically grading essays and open-ended questions. Leveraging GenAI, the platform can assess over five million questions per month, generating scores and comments that educators can review to ensure pedagogical accuracy. The solution has significantly reduced operational costs—to less than 25% of the original—and improved the speed and scalability of evaluations. It also enabled personalised feedback for students while freeing up faculty time for more strategic and enriching academic activities. BASF, one of the world's leading chemical companies, collaborated with CI&T to launch the AI Lab Mixer, an immersive 3D virtual lab experience powered by a virtual assistant named Mixy. Driven by market trends, the platform enables innovation teams to co-create new product concepts in skin care, hair care, and sun protection—generating personalised product names, descriptions, and benefits in real time. This innovative use of GenAI is transforming R&D workflows, accelerating the development of consumer-centric solutions. Robust AWS infrastructure and expertise CI&T's GenAI capabilities are supported by a robust infrastructure built on key AWS services, including Amazon Bedrock, Nova, Lambda, EKS, API Gateway, and SageMaker. The company also boasts a team of over 300 AWS-certified professionals and holds several designations, such as AWS Well-Architected Partner, Migration Competency and Service Delivery Programs for EKS and CloudFront. With a global presence and strong expertise across industries such as education, automotive, manufacturing, healthcare, life sciences, finance, retail, and CPG, CI&T continues to solidify its role as a leading AWS partner — driving purposeful, scalable, and impactful generative AI adoption. About CI&T CI&T (NYSE:CINT) is a global technology transformation specialist for 100+ large enterprises and fast growth clients. CI&T brings a 30-year track record of helping clients navigate change to deliver accelerated business impact, with deep expertise across AI, strategy, customer experience, software development, cloud services, data and more. CI&T's proprietary AI platform, CI&T FLOW boosts team productivity, ensuring fast, efficient, and scalable delivery of world-class solutions. CI&T operates globally, supported by over 7,400 professionals across 10 countries.
Yahoo
22-05-2025
- Business
- Yahoo
Building Trust Through Data: CI&T Releases Report for a More Patient-Centric Healthcare Future
NEW YORK, May 22, 2025--(BUSINESS WIRE)--CI&T (NYSE: CINT), a global technology transformation specialist, today released a new report, Patient-Centric Data Collection: 5 Findings and Opportunities for Every Healthcare Provider, which uncovers a trust gap in patient data handling and highlights opportunities to improve the healthcare experience. The report outlines key findings that point to a common need: a more patient-driven, transparent approach to data collection and management. "Trust in data accuracy, privacy, and accessibility is not just a back-end IT issue – it's an all-around experience issue," said Luiz Cieslak, SVP, Head of Healthcare & Life Sciences at CI&T. "The data shows that improving transparency, digital engagement, and patient autonomy are essential to building trust and improving overall care outcomes." CI&T surveyed 500 U.S. patients who have recently engaged with the healthcare system to gather their perspectives on sharing information with their healthcare provider. To understand how experiences shifted based on sentiment, the survey also captured the respondents' Net Promoter Score (NPS). Promoters—those who rate their likelihood to recommend as 9 or 10—demonstrate strong loyalty and satisfaction, while detractors (0–6) and passives (7–8) reflect lower levels of confidence and engagement. The key findings include: Trust Gaps Undermine Confidence in Data Sharing - patients who are satisfied with their care (promoters) are 45% more likely than unsatisfied patients (detractors) to trust their provider's data-sharing capabilities. Additionally, there's a 41% gap between promoters and detractors in their willingness to trust providers with their personal data, underscoring the need for greater transparency and reassurance around data handling. Patients are Willing to Invest Time on Paperwork, If They Trust the Outcome – Half of patients (52%) reported completing paperwork prior to appointments, with 70% spending more than five minutes doing so. Time spent on forms had minimal impact on satisfaction – as long as patients believed the information would be used to enhance care quality. Digital Pre-Registration Boosts Control but Adoption Lags – While 52% of patients were asked to pre-register online, only 46% followed through. Digital engagement is notably lower among detractors, with just 39% completing pre-registration, compared to 63% of promoters. While Paperwork Is Tolerated, Redundancy Erodes Confidence – 60% of respondents said they had to repeat details like diagnoses, medications, or allergies. While this didn't significantly affect satisfaction scores, it represents a lost opportunity to instill confidence in data accuracy and continuity of care. Patients Want More Control Over Their Records – 50% of respondents report having to correct their data at a recent visit, signaling a larger trend of the importance of patient access and the ability to update records themselves. Download the full report here. About CI&T CI&T (NYSE:CINT) is a global technology transformation specialist for 100+ large enterprises and fast growth clients. CI&T brings a 30-year track record of helping clients navigate change to deliver accelerated business impact, with deep expertise across AI, strategy, customer experience, software development, cloud services, data and more. CI&T's proprietary AI platform, CI&T FLOW boosts team productivity, ensuring fast, efficient, and scalable delivery of world-class solutions. CI&T operates globally, supported by over 7,400 professionals across 10 countries. View source version on Contacts Media Contact Stephanie WheelerIllume PR for CI&Tciandt@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15-05-2025
- Business
- Yahoo
CI&T First Quarter 2025 Earnings: Misses Expectations
Revenue: US$110.9m (up 6.2% from 1Q 2024). Net income: US$7.45m (up 67% from 1Q 2024). Profit margin: 6.7% (up from 4.3% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: US$0.06 (up from US$0.033 in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 27%. Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the IT industry in the US. Performance of the American IT industry. The company's shares are up 12% from a week ago. If you are seeking undervalued stocks, our analysis of 6 valuation measures indicates CI&T could be a good place to look. To explore our complete evaluation click here and get an understanding of what analysts are thinking about the company's future. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
13-05-2025
- Business
- Business Wire
CI&T Reports 13.7% Net Revenue Growth at Constant Currency in 1Q25 Results
NEW YORK--(BUSINESS WIRE)--CI&T (NYSE: CINT, 'Company'), a global technology transformation specialist and fast-growing public company, today announces its results for the first quarter of 2025 (1Q25) in accordance with International Financial Reporting Standards (IFRS), as issued by the IASB. For comparison purposes, we refer to the results for the first quarter of 2024 (1Q24). The numbers are presented in U.S. dollars. First quarter of 2025 (1Q25) highlights Net Revenue of US$110.9 million, a 4.9% increase compared to US$105.7 million in 1Q24. Net Revenue growth at constant currency was 13.7% compared to 1Q24. Net Profit increased by 64.7%, reaching US$7.4 million in 1Q25, up from US$4.5 million in 1Q24. Adjusted EBITDA increased by 15.2% to US$19.6 million in 1Q25 compared to US$17.0 million in 1Q24. The Adjusted EBITDA margin was 17.6% in 1Q25. Adjusted Net Profit increased by 14.2% to US$9.6 million in 1Q25, up from US$8.4 million in 1Q24. The Adjusted Net Profit margin was 8.7% in 1Q25. Diluted earnings per share (EPS) was US$0.05 in 1Q25, an increase of 68.1% compared to US$0.03 in 1Q24. Adjusted diluted EPS was US$0.07 in 1Q25, 16.6% higher than in 1Q24. CI&T ended 1Q25 with 7,399 employees, a 21.6% increase compared to 1Q24. Cesar Gon, founder and CEO of CI&T, commented, 'As we report a strong 13.7% organic constant currency revenue growth, we remain confident in our robust underlying fundamentals and strategic market positioning. Our commitment to innovation and resilience—now strengthened by our AI-driven strategy—is accelerating business transformation and unlocking deeper impact for our clients. We are reaffirming our guidance for 2025, as we continue to drive value for our clients and stakeholders while navigating the evolving market landscape.' The full 1Q25 Earnings Release can be accessed here.
Yahoo
13-05-2025
- Business
- Yahoo
CI&T Reports 13.7% Net Revenue Growth at Constant Currency in 1Q25 Results
NEW YORK, May 13, 2025--(BUSINESS WIRE)--CI&T (NYSE: CINT, "Company"), a global technology transformation specialist and fast-growing public company, today announces its results for the first quarter of 2025 (1Q25) in accordance with International Financial Reporting Standards (IFRS), as issued by the IASB. For comparison purposes, we refer to the results for the first quarter of 2024 (1Q24). The numbers are presented in U.S. dollars. First quarter of 2025 (1Q25) highlights Net Revenue of US$110.9 million, a 4.9% increase compared to US$105.7 million in 1Q24. Net Revenue growth at constant currency was 13.7% compared to 1Q24. Net Profit increased by 64.7%, reaching US$7.4 million in 1Q25, up from US$4.5 million in 1Q24. Adjusted EBITDA increased by 15.2% to US$19.6 million in 1Q25 compared to US$17.0 million in 1Q24. The Adjusted EBITDA margin was 17.6% in 1Q25. Adjusted Net Profit increased by 14.2% to US$9.6 million in 1Q25, up from US$8.4 million in 1Q24. The Adjusted Net Profit margin was 8.7% in 1Q25. Diluted earnings per share (EPS) was US$0.05 in 1Q25, an increase of 68.1% compared to US$0.03 in 1Q24. Adjusted diluted EPS was US$0.07 in 1Q25, 16.6% higher than in 1Q24. CI&T ended 1Q25 with 7,399 employees, a 21.6% increase compared to 1Q24. Cesar Gon, founder and CEO of CI&T, commented, "As we report a strong 13.7% organic constant currency revenue growth, we remain confident in our robust underlying fundamentals and strategic market positioning. Our commitment to innovation and resilience—now strengthened by our AI-driven strategy—is accelerating business transformation and unlocking deeper impact for our clients. We are reaffirming our guidance for 2025, as we continue to drive value for our clients and stakeholders while navigating the evolving market landscape." The full 1Q25 Earnings Release can be accessed here. View source version on Contacts Investor Relations Contact: Eduardo Galvãoinvestors@ Media Relations Contact: Zella Panossianciandt@ Sign in to access your portfolio
